222 related articles for article (PubMed ID: 31674704)
21. Determining the pathogenicity of CFTR missense variants: Multiple comparisons of in silico predictors and variant annotation databases.
Michels M; Matte U; Fraga LR; Mancuso ACB; Ligabue-Braun R; Berneira EFR; Siebert M; Sanseverino MTV
Genet Mol Biol; 2019; 42(3):560-570. PubMed ID: 31808782
[TBL] [Abstract][Full Text] [Related]
22. Molecular Diagnosis of Cystic Fibrosis.
Deignan JL; Grody WW
Curr Protoc Hum Genet; 2016 Jan; 88():9.28.1-9.28.6. PubMed ID: 26724724
[TBL] [Abstract][Full Text] [Related]
23. Pred-MutHTP: Prediction of disease-causing and neutral mutations in human transmembrane proteins.
Kulandaisamy A; Zaucha J; Sakthivel R; Frishman D; Michael Gromiha M
Hum Mutat; 2020 Mar; 41(3):581-590. PubMed ID: 31821684
[TBL] [Abstract][Full Text] [Related]
24. UMD-CFTR: a database dedicated to CF and CFTR-related disorders.
Bareil C; Thèze C; Béroud C; Hamroun D; Guittard C; René C; Paulet D; Georges Md; Claustres M
Hum Mutat; 2010 Sep; 31(9):1011-9. PubMed ID: 20607857
[TBL] [Abstract][Full Text] [Related]
25. Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Variants in Individuals Evaluated for Primary Ciliary Dyskinesia.
Hannah WB; Truty R; Gonzales V; Kithcart GP; Ouyang K; Zeman MK; Li C; Drumm M; Nykamp K; Gaston BM
J Pediatr; 2019 Dec; 215():172-177.e2. PubMed ID: 31610925
[TBL] [Abstract][Full Text] [Related]
26. Mild cystic fibrosis in patients with the rare P5L CFTR mutation.
Spicuzza L; Sciuto C; Di Dio L; Mattina T; Leonardi S; del Giudice MM; La Rosa M
J Cyst Fibros; 2012 Jan; 11(1):30-3. PubMed ID: 21983161
[TBL] [Abstract][Full Text] [Related]
27. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
[TBL] [Abstract][Full Text] [Related]
28. mirVAFC: A Web Server for Prioritizations of Pathogenic Sequence Variants from Exome Sequencing Data via Classifications.
Li Z; Liu Z; Jiang Y; Chen D; Ran X; Sun ZS; Wu J
Hum Mutat; 2017 Jan; 38(1):25-33. PubMed ID: 27676360
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of CFTR in the Ecuadorian population using next-generation sequencing.
Ruiz-Cabezas JC; Barros F; Sobrino B; García G; Burgos R; Farhat C; Castro A; Muñoz L; Zambrano AK; Martínez M; Montalván M; Paz-Y-Miño C
Gene; 2019 May; 696():28-32. PubMed ID: 30763667
[TBL] [Abstract][Full Text] [Related]
30. Identification of a cystic fibrosis mutation W19X in Tunisia.
Boudaya M; Fredj SH; Siala H; Bibi A; Messaoud T
Ann Biol Clin (Paris); 2013; 71(2):223-6. PubMed ID: 23587593
[TBL] [Abstract][Full Text] [Related]
31. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series.
Villalona S; Glover-López G; Ortega-García JA; Moya-Quiles R; Mondejar-López P; Martínez-Romero MC; Rigabert-Montiel M; Pastor-Vivero MD; Sánchez-Solís M
J Med Case Rep; 2017 Feb; 11(1):42. PubMed ID: 28196530
[TBL] [Abstract][Full Text] [Related]
32. Variant Calling From Next Generation Sequence Data.
Hansen NF
Methods Mol Biol; 2016; 1418():209-24. PubMed ID: 27008017
[TBL] [Abstract][Full Text] [Related]
33. A novel missense mutation A1081P in the cystic fibrosis transmembrane conductance regulator (CFTR) gene identified in a Laotian patient with congenital bilateral absence of the vas deferens.
Ngukam A; Jacquemont ML; Souville I; Viel M; Beldjord C; Hubert D; Hughes JN; Bienvenu T
J Trop Pediatr; 2004 Aug; 50(4):239-40. PubMed ID: 15357566
[TBL] [Abstract][Full Text] [Related]
34. CFTR gene variants, epidemiology and molecular pathology.
Bareil C; Bergougnoux A
Arch Pediatr; 2020 Feb; 27 Suppl 1():eS8-eS12. PubMed ID: 32172939
[TBL] [Abstract][Full Text] [Related]
35. Current and future molecular approaches in the diagnosis of cystic fibrosis.
Bergougnoux A; Taulan-Cadars M; Claustres M; Raynal C
Expert Rev Respir Med; 2018 May; 12(5):415-426. PubMed ID: 29580110
[TBL] [Abstract][Full Text] [Related]
36. Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.
Sosnay PR; Salinas DB; White TB; Ren CL; Farrell PM; Raraigh KS; Girodon E; Castellani C
J Pediatr; 2017 Feb; 181S():S27-S32.e1. PubMed ID: 28129809
[TBL] [Abstract][Full Text] [Related]
37. KVarPredDB: a database for predicting pathogenicity of missense sequence variants of keratin genes associated with genodermatoses.
Ying Y; Lu L; Banerjee S; Xu L; Zhao Q; Wu H; Li R; Xu X; Yu H; Neculai D; Xi Y; Yang F; Qin J; Li C
Hum Genomics; 2020 Dec; 14(1):45. PubMed ID: 33287903
[TBL] [Abstract][Full Text] [Related]
38. S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy.
Terlizzi V; Di Lullo AM; Comegna M; Centrone C; Pelo E; Castaldo G; Raia V; Braggion C
Ital J Pediatr; 2018 Jan; 44(1):2. PubMed ID: 29298718
[TBL] [Abstract][Full Text] [Related]
39. Genetics of Cystic Fibrosis: Clinical Implications.
Egan ME
Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
[TBL] [Abstract][Full Text] [Related]
40. The multi-faceted nature of 15 CFTR exonic variations: Impact on their functional classification and perspectives for therapy.
Bergougnoux A; Billet A; Ka C; Heller M; Degrugillier F; Vuillaume ML; Thoreau V; Sasorith S; Bareil C; Thèze C; Ferec C; Gac GL; Bienvenu T; Bieth E; Gaston V; Lalau G; Pagin A; Malinge MC; Dufernez F; Lemonnier L; Koenig M; Fergelot P; Claustres M; Taulan-Cadars M; Kitzis A; Reboul MP; Becq F; Fanen P; Mekki C; Audrezet MP; Girodon E; Raynal C
J Cyst Fibros; 2023 May; 22(3):515-524. PubMed ID: 36567205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
